Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q1 2019 · 10-Q
Revenue$65.27K$65.27K−55.8% vs Q1 2018 Net Income-$1.77M-$1.77MN/M vs Q1 2018 EPS Diluted-$0.67-$0.67N/M vs Q1 2018 Operating Income-$1,480,370N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
Free Cash Flowderived-$360,987— Margins · derivedOperating margin-2267.9%−1903.1 pt vs Q1 2018
Net margin-2712.4%−2034.3 pt vs Q1 2018
ended Mar 31, 2019 · filed May 15, 2019 · 45 d after period end